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Summary The interferons are a group of naturally occuring proteins that inhibit the growth of tumours in
vivo and many transformed cell lines in vitro. The mechanisms of action of interferon, however, remain
unclear. The IFN induced inhibition of growth of many epithelial cancer cell lines is associated with changes
in Epidermal Growth Factor Receptor (EGFR) binding or expression. Therefore, we examined the effect of
IFN treatment on the expression of EGFR in a human breast carcinoma cell line, MDA 468. We have found
the IFN-y inhibited, in a dose dependent fashion, the growth of MDA 468 cells. IFN decreased cell surface
binding of 25I-EGF to EGFR by changing receptor number rather than affinity. However, total cellular
receptor protein, as measured by immunoprecipitation with monoclonal antibodies, was increased in IFN-
treated cells. The half-life of the metabolically labelled receptor was unchanged by treatment with IFN.
Increased amounts of EGFR mRNA were observed in MDA 468 cells treated with IFN-y for 3 days. The
levels of mRNA increased with time in culture, reaching a peak of four times control values after 5 days of
treatment. This effect was observable with as little as 10 U ml' of IFN-y. Treatment of the cells with
Actinomycin D to inhibit new RNA synthesis suggested that the stability of EGFR mRNA was not enhanced
in IFN-y treated cells. The increase in receptor mRNA induced by IFN was not inhibited by cycloheximide.
These data suggest IFN-y can increase expression of EGFR mRNA and protein in MDA 468 cells. Increased
expression of EGFR mRNA and protein by IFN-y is associated with inhibition of cell growth.
Interferons are a family of secretory cellular proteins with a
wide range of biological effects. In addition to their antiviral
activity, IFNs inhibit growth of both normal and trans-
formed cells (Balkwill et al., 1982; Bradley & Ruscetti, 1981).
Although the inhibitory actions of IFNs on cell proliferation
have been recognised for many years, the mechanisms under-
lying this effect have not yet been identified.
One hypothesis to explain IFNs antiproliferative activity
suggests that IFN may modulate growth factor action.
Inhibition of growth of several epithelial cell lines is assoc-
iated with changes in binding of Epidermal Growth Factor
(EGF) to its receptor. For example, Chang et al. (1986) have
demonstrated that treatment of the squamous epithelial cell
line A431 with IFN-y results in morphologic changes
associated with cell differentiation. Death of A431 cells after
exposure to IFN-y is associated with an increase in expres-
sion of 10 kb mRNA species for EGFR. This group further
demonstrated (Bernstein et al., 1988) that IFN both inhibits
the growth of a variety of squamous cell carcinoma cell
lines, the majority of which normally overexpress EGFR
mRNA, and elevates levels of EGF receptor mRNA. In
contrast, Zoon et al. (1986) have demonstrated that IFN-a
inhibits EGF-stimulated growth of MDBK cells, and reduces
binding of EGF to its receptor. Nickloff and Mitra (1989)
have noted that IFN-y inhibits growth of human keratino-
cytes and reduces the number of EGF binding sites.
Generally, IFN's increase EGFR mRNA expression in cells
expressing amplified levels of EGFR mRNA pre-treatment,
and decrease expression in cells with normal levels of EGFR.
We have been studying the possible interaction between
IFN and EGF in control of the growth of the MDA 468
breast tumour cell line. MDA 468 cells contain greatly
amplified numbers of EGFR and five copies of the gene for
EGFR. We have found that IFN-y inhibits the growth of this
cell line. In contrast to studies by Bernstein et al. (1988), we
found this growth inhibition was associated with decreased
binding of '25I-EGF to cell surface receptors due to a change
in receptor number rather than affinity (Chakravarthy et al.,
1991). The purpose of the present study was to examine the
effect of IFN on synthesis and stability of the EGFR protein
and mRNA.
Materials and methods
Cell culture
The MDA 468 cell line (kindly provided by Dr Ron Buick,
Ontario Cancer Institute) was derived from a human breast
carcinoma (Filmus et al., 1985). It was routinely cultured in
L-15 medium (Gibco) supplemented with 10% foetal bovine
serum (FBS) (Sigma, St Louis, MO). Cells were subcultured
twice weekly by trypsinisation. All cells were used within 20
passages of the original stock.
Protein labelling and immunoprecipitation
MDA 468 cells (6 x 105 total) were plated in 75 cm2 flasks in
50% DMEM, 50% F-12 medium with 10% calf-serum.
Medium were aspirated, the cells rinsed with methionine-free
RPMI (ABS, Columbia, MD) and incubated for 6 h with
"5Smethionine (38piCi ml-') (S.A. 1129 Ci mmol-') (New
England Nuclear, Boston, MA) in 5ml methionine free
RPMI. Cells were lysed in 1 ml of 50 mM Tris HCI, Triton
X-100 (1% v/v), SDS (0.1% w/v), PMSF (1 mM), EDTA
(1 mM) and leupeptin (1 ,Ag ml-') at room temperature. Cell
lysates were centrifuged and duplicate aliquots of each lysate
were standardised by trichloroacetic acid precipitation. The
samples were then incubated with a monoclonal antibody to
EGF receptor (antibody 528) (final concentration of 1.5 jig
ml-') (Oncogene Science Inc, Mineola, NY) or a non-specific
antibody of the same isotype and Protein-A Sepharose.
Bound material was released by heating the complexes in
SDS buffer for 2 min at 100°C. The samples were then
analysed on 7.5% SDS polyacrylamide gels. Following elec-
trophoresis, the gels were treated with Enhance (NEN) and
dried. The gels were exposed to Kodak XAR-5 film and
developed. Where indicated, the relative amounts of
immunoprecipitated EGF receptor were quantitated by den-
sitometric analysis of the autoradiograms using a LKB laser
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densitometer with peak integration. Radioactivity incorpor-
ated into bands on dried gels was also directly quantitated
using a Betascope analyser (Betagen, Cambridge, MA).
RNA extraction and Northern blot analysis
Total RNA was isolated from MDA 468 cells with guani-
dinium thiocyanate as described (Chirgwin et al., 1979) and
quantitated by absorbance at 260 nm. Quantitation was
confirmed by electrophoretically fractionating a sample on
formaldehyde agarose gels, staining with ethidium bromide,
and observing the intensities of the ribosomal RNA bands.
Twenty fig of total RNA were denatured and analysed by
electrophoresis on 1% agarose-formaldehyde gels for 5 h at
70 V, and then transferred to nitrocellulose paper by capil-
lary blotting. Sample lanes were stained with methylene blue
on the filters to verify that equal amounts of total RNA were
transferred. Hybridisations were performed at 42°C in the
presence of 50% (v/v) deionised formamide with the cDNA
clone pE7 that encodes a portion of the human EGF recep-
tor. The purified 2.4 kb insert was labelled with 32P x-dCTP
using random priming (Amersham, Arlington Hgts, IL). At
the end of the hybridisation, the blots were washed as pre-
viously described (Filmus et al., 1987) with the final wash of
0.1% SDS, 2 x SSC (1 x SSC = 0.15 M NaCl, 0.015 M
sodium citrate) for 45 min at 55°C. Hybridisation signals on
the blot were quantitated using the Betascope analyser which
directly measured d.p.m. in individual dots or bands. After
boiling off the bound probe, blots were rehybridised with a
770 base pair human P actin cDNA probe from Oncor
(Gaithersburg, MD).
Results
Biosynthesis and degradation ofthe EGF receptor
In previous studies, we found that IFN-y decreased growth
of MDA 468 cells in a dose dependent manner. We also
found decreased binding of 'l25-labelled EGF to IFN treated
cells after 4-5 days of IFN treatment due to a change in
receptor numbers, rather than affinity (Chakravarthy et al.,
1991). To determine if this decreased binding was due to
decreases in synthesis of EGFR, we examined the synthesis
of EGFR in control and IFN treated cells. Cells were meta-
bolically labelled with "Smethionine and EGFR immuno-
precipitated with a monoclonal antibody directed to a
polypeptide epitope present in the external domain of the
receptor. Despite decreases in cell surface binding, we found
increased amounts of EGFR protein (approximately 3-fold
as determined by densitometric scanning) in IFN treated cells
after 4 days of IFN treatment (Figure 1). To determine if this
increase of EGFR protein in IFN treated cells was due to
increased stability of the protein, we performed pulse-chase
experiments as described (Bjorge & Kuldow, 1987). MDA
468 cells were metabolically labelled with "Smethionine for
6 h. The culture medium containing the labelled methionine
was replaced with medium containing unlabelled methionine
(600 pg ml-'). At various times after addition of cold
methionine, the cell monolayers were solubilised and the
EGF receptor quantitatively immunoprecipitated and analy-
sed by gel electrophoresis. The amount of labelled receptor
remaining at various times of exposure was quantitated by
determining the amount of radioactivity in the receptor band
using a Betascope analyser. The amount of EGF in both
control and IFN treated cells diminished slowly. Fifty-four
per cent of the originally labelled receptor remained after
48 h in both control and IFN treated cells (Figure 2a and b).
In contrast, Bjorge and Kudlow (1987) reported a half-life of
24 h for EGFR protein in untreated MDA 468 cells. These
results indicated that despite decreased binding of EGF to its
receptor, increased amounts of protein were being syn-
thesised. In addition, the stability of the EGFR protein was
unchanged between control and IFN treated cells.
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Figure 1 Effects of IFN on the amount of immunoprecipitable
EGF receptor (EGFR) protein in control and IFN-treated cells.
MDA 468 cells were exposed for 4 days to 500 U ml-' IFN-'y. At
the indicated times, the cells were lysed and the receptor was
immunoprecipitated as described. A typical autoradiogram is
shown. Similar results were obtained in three separate experi-
ments. A = control cells, B = IFN treated-cells.
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Figure 2 Effect of IFN on the degradation rate of the EGF
receptor. MDA 468 cells were treated with IFN for 4 days and
then labelled for 6h with "Smethionine. The cell monolayers
were washed and the label was chased in growth medium with
excess methionine. At the indicated times, the cells were lysed and
the receptor immunoprecipitated. The immunoprecipitates were
run on SDS gels, and the labelled protein detected by autoradiog-
raphy a. The numbers of d.p.m. in the 170 kd bands at all time
points were directly assessed using a Betascope counter. One
hundred per cent: control cells = 2530 d.p.m., 100% IFN-treated
cells= 8496 d.p.m. b. 0 0 CON; * * IFN.
Effect ofIFN on EGFR mRNA synthesis
Both control and IFN treated cells were examined for the
presence of steady state levels of mRNA transcript for
EGFR after 4 days of IFN treatment, a time just prior to
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inhibition of cell proliferation. RNAs were prepared from
MDA 468 cells grown in the presence of 500 IL ml IFN-y and
analysed by RNA blotting. Figure 3 shows increased levels of
mRNA for EGFR in cells treated with IFN for 4 days.
EGFR mRNA levels of IFN-treated cells were approximately
three times those observed in control cells.
Northern analysis revealed the presence of two species of
EGFR receptor mRNA (10 and 5.6 kb) as had been report-
ed. Both the 10 and 5.6 kb species were increased in IFN-
treated cells (Figure 4). Rehybridisation of the same blot with
a probe for P-actin did not shown any variation in the levels
of this mRNA.
To determine the kinetics of the effect of IFN-y on the
expression of EGF receptor gene, MDA 468 cells were
exposed to IFN-y at 500 1 ml1' for various periods of time.
Samples of RNA from each of the time points were dotted
onto nylon membranes and the blot was hybridised to the
pE7 probe. The amount of hybridisation was quantitated by
analysis on a Betascope. At 1 (Figure 5) and 2 (data not
shown) days of IFN treatment, the steady-state levels of
EGFR mRNA were equal in control and IFN-treated cells.
Increases were initially observed at 3 days of treatment
(approximately 3-fold). After 5 days of treatment, the steady-
state level of EGFR mRNA was increased 4-fold (Figure 5).
The increases were due both to increases in EGFR mRNA
with time in IFN-treated cells, and decreases in EGFR
mRNA level in control cells (Hamburger et al., 1991). Riz-
zino et al. (1988) have similarly noted that EGFR binding
decreases in both normal and malignant cell lines as cell
density increases.
We also analysed RNA obtained from MDA 468 cells
treated for 4 days with increasing concentrations of IFN.
Figure 6 shows that the level of EGF receptor mRNA in-
creased progressively with increasing concentrations of IFN.
As little as 10 U ml-' of IFN-y enhanced the expression of
EGFR mRNA 1.9-fold. Maximal levels of EGF receptor
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Figure 5 Effect of IFN on EGFR mRNA levels in MDA 468
cells. MDA 468 cells were incubated for I to 5 days as described.
Cells were harvested at days 1, 3 and 5, total mRNA extracted,
and equal amounts of RNA dotted onto nitrocellulose filters at
either 2.5 Ag or 5 gg per dot. The filters were hybridised to a
cDNA probe for the EGF receptor as described.
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Figure 3 Effect of IFN on EGF receptor mRNA levels in MDA
468 cells. MDA 468 cells were treated with 500 U ml-' IFN for 4
days. After incubation, RNA was extracted, and dotted onto
nitrocellulose filters at the concentrations (in jig) indicated. The
filters were hybridised with a cDNA probe for the EGF receptor
as described. An autoradiogram representative of three trials is
shown.
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Figure 4 Northern blot analysis of the effect of IFN on EGF
receptor mRNA. Cells were treated with IFN (500 U ml-') for 4
days and total RNA prepared as described. RNA (201sg per lane)
was electrophoresed in 1% agarose-2.2 M formaldehyde gels, the
RNA transferred to nitrocellulose filters, and hybridised to a
cDNA probe for EGF receptor as described. Lane A, control
cells; Lane B, interferon treated cells.
Figure 6 Effect of increasing concentrations of IFN-y on EGFR
mRNA levels. MDA 468 cells were treated with the indicated
concentrations of IFN-y (U ml-') for 4 days. Cells were harvest-
ed, total mRNA extracted, 2.5 or 5pg of RNA dotted onto
nitrocellulose filters, and the filters were hybridised to a cDNA
probe for the EGF receptor as described.
mRNA were reached at approximately 100fi ml-' (Figure 6).
To determine if the increase in EGFR mRNA induced by
IFN after 4 days was due to inactivation of labile repressor
proteins, we examined the effects of cycloheximide on EGFR
expression (Figure 7). Cycloheximide alone increased message
accumulation in untreated MDA 468 cells as previously des-
cribed by Clark et al. (1985). Addition of cycloheximide to
IFN-treated cells failed to inhibit the IFN-induced increase
(Figure 7). However, pre-treatment of cells with IFN-y
prevented the cycloheximide induced increases.
We also examined the effect of IFN treatment on EGFR
mRNA half life as described (Fernandez-Pol et al., 1987).
Cell were treated for 4 days with IFN-y, at which time EGF
receptor transcipts levels were still increasing, yet elevated
3-4-fold above control levels. Cells were then treated with
high dose Actinomycin D (5 ig ml1') to shut off all trans-
criptional activity. The survival of EGFR mRNA was deter-
mined at 0.5, 1, 2, and 3 h after the Actinomycin D chase onIFN-y REGULATION OF EGFR mRNA 67
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Figure 7 Effect of cycloheximide (CH) on induction of EGF
receptor mRNA by interferon. Cells were treated with either
IFN-y (500 tml ') for 4 days, 10jug ml- I CH for the last 4h, or
both, and total RNA isolated and analysed on Northern blots as
described. Lane A, untreated cells; Lane B, CH; Lane C, IFN;
Lane D, IFN +CH.
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Figure 8 Effect of IFN on EGF receptor transcript half-life in
MDA 468 cells. Cells were treated with IFN (500 U ml-') for 4
days prior to the addition of 5 ,g ml-' of actinomycin D for
various times. Total RNA was collected at the times indicated.
Receptor levels were determined by Northern analysis. To cal-
culate the decay plot, the number of counts in the 10 kb band, as
determined by the Betascope were used. For IFN-treated cells
that equalled 5168±420 at time 0 and for control cells 1910+
207 d.p.m. This figure represents the mean of two separate
experiments.
an RNA blot. First order kinetics of decay were assumed in
calculating transcript half-lives. Interferon treatment had no
effect on the apparent half-life of approximately 1 h for the
EGF receptor transcript in both control and IFN treated
cells. These results suggest that interferon does not increase
EGF receptor mRNA levels by increasing message stability.
Discussion
We have previously demonstrated that IFN--y decreases
growth of the MDA-468 breast carcinoma cell line. Inter-
ferons have long been noted to decrease growth of human
breast tumour cell lines in culture and of human tumour
xenografts in nude mice (Balkwill et al., 1982). However, the
cellular mechanisms of the antiproliferative effect have not
yet been defined.
A large body of evidence indicates IFNs can modulate
growth factor receptor physiology, and that this phenomenon
may be partially responsible for IFNs' antiproliferative effect.
For cells bearing normal numbers of EGF receptors, inhibi-
tion of growth by IFN is generally accompanied by decreased
receptor binding. Thus, Zoon et al. (1986) have demonstrated
that IFN-a inhibits the EGF-stimulated growth of MDBK
cells by decreasing EGF binding to its cell surface receptor.
Nickloff and Mitra (1989). have noted that IFN-,y inhibits
growth of human keratinocytes and reduces the number of
EGF binding sites on these cells.
The effect of IFN on cells which usually display high
numbers of EGF receptors is less clear. In this paper, we
have shown that IFN stimulated the synthesis of EGF recep-
tor protein in the MDA 468 human breast cancer cell line.
The increase in protein synthesis was accompanied by an
increase in accumulation of EGFR mRNA. This is the first
demonstration of this effect in a human breast carcinoma cell
line. Our data extend and support previous reports in which
the antiproliferative effect of IFN-y on A431 cells and other
squamous cell lines is associated with an increased expression
of the 10kb mRNA for EGF receptor (Bernstein et al.,
1988). In that system, IFN-y treatment also enhances cellular
differentiation. It has been proposed that IFN-i exerts its
antiproliferative effect via acceleration of terminal different-
iation. Enhanced expression of EGFR may be one event in
this differentiation program. We have not observed any
obvious morphological changes in IFN-y treated MDA 468
cells that would suggest IFN induced cell differentiation. We
are currently examining the effect of IFN on induction of
oestrogen receptor in this oestrogen receptor negative line, as
several groups have suggested IFN enhances ER expression
in breast carcinoma cell lines (van den Berg et al., 1987;
Goldstein et al., 1989).
It is of interest to note that our previous studies have
indicated binding of EGFR to its receptor is decreased by
IFN treatment (Chakravarthy et al., 1991). A decrease in the
number of receptors, rather than a change in receptor affinity
was noted. The seemingly paradoxical increase of EGFR
protein and mRNA remains to be explored, but is not unpre-
cendented. Raymond et al. (1990) found that treatment of rat
liver epithelial cells with retinoic acid decreases the level of
EGF binding, but increases receptor biosynthesis and steady
state levels of EGFR mRNA. The decreases in binding were
due to a change in receptor affinity. In our system, it is likely
that the secretion of EGF-competing substances may be
blocking cell surface receptors. We have found that IFN
treatment can increase the secretion of TGF-ac by these cells
(data not shown). Similarly, Kumar and Mendelsohn (1990)
have shown that treatment of A431 cells with IFN-y
enhances expression of TGF-m. In addition, IFN-y inhibits
growth of human keratinocytes, decreases EGF binding, and
increases TGF-a production (Nickloff & Mitra, 1989). In
MDA 468 cells, IFN-'y may stimulate TGF-c secretion and
block external EGF receptors. Alternatively, TGF-xo may be
present in an uncleaved transmembrane form that blocks
binding to EGF to its receptor (Brachmann et al., 1989).
Increased secretion of TGF-o could also be responsible for
the IFN-y induced stimulation of EGFR synthesis, as TGF-a
enhances EGFR synthesis in the cell line (Bjorge et al., 1989).
In the present study, IFN-y induced increases in EGFR
mRNA and protein, while inhibiting cell growth. Increases in
EGFR transcription and biosynthesis were observed prior to
the onset of cytostasis. However, although increases of
EGFR protein are clearly associated with inhibition of cell
growth, a causal relationship has not been established.
Generally, the relationship between cell growth and the
amount of EGFR receptor protein on cells is unclear.
Increased numbers of EGF receptors on human breast car-
cinoma biopsies have been correlated with a poor clinical
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prognosis (Sainsbury et al., 1987). It has been assumed that
increased numbers of EGF receptors results in an increased
response to the mitogenic effect of EGF. However, the
growth of many cell lines with very high numbers of EGF
receptors (including MDA 468 and A431 cells) is inhibited by
EGF. A simple correlation between the number of EGF
receptors and mitogenic activity of EGF does not exist.
In summary, our results indicate that IFN-y enhanced
expression of EGFR mRNA and protein in a human breast
carcinoma cell line. These changes were accompanied by a
decrease in cell growth. Our studies support a growing body
of literature that indicates the importance of the interaction
between interferon and growth factors in the regulation of
cell growth.
We wish to thank Florence Wade and Helen Spiker for preparation of
the manuscript. This work was supported by Grant #RO1 Ca 48193
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